new BindingDB logo
myBDB logout

18 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
25549897 36 Novel 3-(1H-indol-3-yl)-2-[3-(4-methoxyphenyl)ureido]propanamides as selective agonists of human formyl-peptide receptor 2.EBI Universit£ degli Studi di Bari 'Aldo Moro'
25587631 5 Pachymodulin, a new functional formyl peptide receptor 2 peptidic ligand isolated from frog skin has Janus-like immunomodulatory capacities.EBI Sorbonne Universit£s
25035262 41 Development of potent antagonists for formyl peptide receptor 1 based on Boc-Phe-D-Leu-Phe-D-Leu-Phe-OH.EBI Saga University
25254640 64 Discovery of 2-[5-(4-Fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic Acid (SX-517): Noncompetitive Boronic Acid Antagonist of CXCR1 and CXCR2.EBI Syntrix Biosystems
22094028 31 Lead optimisation of pyrazoles as novel FPR1 antagonists.EBI AstraZeneca
21955939 49 Discovery of pyrazoles as novel FPR1 antagonists.EBI AstraZeneca
21486695 11 Discovery of small molecule human FPR1 receptor antagonists.EBI AstraZeneca
17475488 13 2-Phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives: new potent inhibitors of fMLP-induced neutrophil chemotaxis.EBI Universit£ di Genova
12361388 47 Cyclosporins: structure-activity relationships for the inhibition of the human FPR1 formylpeptide receptor.EBI Strasbourg 1 University
19639995 81 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors.EBI Universita degli Studi di Firenze
8676333 46 N-terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor.EBI Johnson Matthey Biomedical Research
 5 NAD+-dependent DNA ligase (Rv3014c) from M. tuberculosis: Strategies for inhibitor designBDB Central Drug Research Institute
 10 Design and synthesis of new 2-aryl, 3-benzyl- (1,3-oxazolidine or 1,3-thiazolidine)-4-ones as selective cyclooxygenase (COX-2) inhibitorBDB Shahid Beheshti University